Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jul;35(7):1360–1364. doi: 10.1128/aac.35.7.1360

Cefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications.

D Swanson 1, R A Maxwell 1, J T Johnson 1, R L Wagner 1, V L Yu 1
PMCID: PMC245172  PMID: 1929293

Abstract

Perioperative single-dose antibiotic prophylaxis of cefonicid was compared with clindamycin in a prospective, randomized, double-blind trial of patients undergoing oncologic head and neck surgery. Antibiotics were administered intravenously beginning 1 to 2 h preoperatively. Cefonicid, 1 g, was given as a single dose. Clindamycin, 600 mg, was administered every 8 h for a total of four doses. Blood and wound drainage samples were collected for 24 h following the dose of cefonicid and assayed for total and free cefonicid concentrations, using reverse-phase high-performance liquid chromatography. Although total concentrations of cefonicid in both serum and wound drainage exceeded the MIC for 90% of the isolates of common bacterial pathogens for 24 h, free concentrations in serum and wound drainage (11.0 and 14.9% of total concentrations) were subinhibitory within 6 h following administration. Free concentrations of cefonicid in the postoperative wound drainage were subinhibitory for the entire study period, both perioperatively and postoperatively. Postoperative wound infection occurred significantly (P less than 0.05) more frequently in patients receiving cefonicid (24%) as compared with those receiving clindamycin (8.2%). The relatively low free levels of cefonicid achieved in serum and wound drainage were attributed to the high degree of protein binding (89% in serum) and may be related to the poor clinical outcome.

Full text

PDF
1360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Actor P., Uri J. V., Zajac I., Guarini J. R., Phillips L., Pitkin D. H., Berges D. A., Dunn G. L., Hoover J. R., Weisbach J. A. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother. 1978 May;13(5):784–790. doi: 10.1128/aac.13.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barriere S. L., Hatheway G. J., Gambertoglio J. G., Lin E. T., Conte J. E., Jr Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1982 Jun;21(6):935–938. doi: 10.1128/aac.21.6.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dudley M. N., Shyu W. C., Nightingale C. H., Quintiliani R. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans. Antimicrob Agents Chemother. 1986 Oct;30(4):565–569. doi: 10.1128/aac.30.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnson J. T., Yu V. L. Antibiotic use during major head and neck surgery. Ann Surg. 1988 Jan;207(1):108–111. doi: 10.1097/00000658-198801000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johnson J. T., Yu V. L., Myers E. N., Wagner R. L. An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis. 1987 Feb;155(2):331–333. doi: 10.1093/infdis/155.2.331. [DOI] [PubMed] [Google Scholar]
  7. Nightingale C. H., Quintiliani R., Dudley M. N., Gough P., Hickingbotham M., Jordan N. S., Rose D., Toscani M. Tissue penetration and half-life of cefonicid. Rev Infect Dis. 1984 Nov-Dec;6 (Suppl 4):S821–S828. doi: 10.1093/clinids/6.supplement_4.s821. [DOI] [PubMed] [Google Scholar]
  8. Peterson L. R., Gerding D. N. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev Infect Dis. 1980 May-Jun;2(3):340–348. doi: 10.1093/clinids/2.3.340. [DOI] [PubMed] [Google Scholar]
  9. Phelps R. T., Conte J. E., Jr Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function. Antimicrob Agents Chemother. 1986 May;29(5):913–917. doi: 10.1128/aac.29.5.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Piccart M., Dor P., Klastersky J. Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis Suppl. 1983;39:92–96. [PubMed] [Google Scholar]
  11. Rocci M. L., Jr, Jusko W. J. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Programs Biomed. 1983 Jun;16(3):203–216. doi: 10.1016/0010-468x(83)90082-x. [DOI] [PubMed] [Google Scholar]
  12. Rubin J., Johnson J. T., Wagner R. L., Yu V. L. Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg. 1988 Sep;114(9):969–972. doi: 10.1001/archotol.1988.01860210035010. [DOI] [PubMed] [Google Scholar]
  13. Stoehr G. P., Yu V. L., Johnson J. T., Antal E. J., Townsend R. J., Wagner R. Clindamycin pharmacokinetics and tissue penetration after head and neck surgery. Clin Pharm. 1988 Nov;7(11):820–824. [PubMed] [Google Scholar]
  14. Trang J. M., Monson T. P., Ackerman B. H., Underwood F. L., Manning J. T., Kearns G. L. Effect of age and renal function on cefonicid pharmacokinetics. Antimicrob Agents Chemother. 1989 Feb;33(2):142–146. doi: 10.1128/aac.33.2.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet. 1986 Nov-Dec;11(6):470–482. doi: 10.2165/00003088-198611060-00004. [DOI] [PubMed] [Google Scholar]
  16. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978 Dec;6(6):547–558. doi: 10.1007/BF01062109. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES